Literature DB >> 22126592

National survey of malignant mesothelioma and asbestos exposure in Japan.

Kenichi Gemba1, Nobukazu Fujimoto, Katsuya Kato, Keisuke Aoe, Yukio Takeshima, Kouki Inai, Takumi Kishimoto.   

Abstract

In the present study, malignant mesothelioma (MM) cases in Japan were investigated retrospectively. We extracted records for 6030 cases of death due to MM between 2003 and 2008 to clarify the clinical features of MM, including its association with asbestos exposure (AE). Of all these cases, a clinical diagnosis of MM was confirmed for 929. The origin of MM included the pleura in 794 cases (85.5%), the peritoneum in 123 cases (13.2%), the pericardium in seven cases (0.8%), and the testicular tunica vaginalis in five cases (0.5%). The histological subtypes of MM included 396 epithelioid (55.9%), 154 sarcomatoid (21.7%), 126 biphasic (17.8%), and 33 cases (4.7%) classified as "other types". Of all the MM cases, AE was indicated in 76.8% and pleural plaques were detected in 34.2%. The number of asbestos particles was determined in 103 cases of MM. More than 1000 asbestos particles per gram dried lung tissue were detected in 74.8% of cases and more than 5000 particles were detected in 43.7% of cases. We compared patient characteristics and the diagnostic procedures for MM before and after the "Kubota shock". Compared with the early phase of this study (2003-2005), the median age at diagnosis of MM was higher, the number of cases without definite diagnosis of MM was lower, the proportion of cases diagnosed by thoracoscopy was higher, and the percentage of cases in which the occupational history was described in the medical records was significantly higher in the later phase (2006-2008). Our study confirmed that more than 70% of MM cases in Japan are associated with AE. The "Kubota shock" may affect some features pertaining to MM.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22126592     DOI: 10.1111/j.1349-7006.2011.02165.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  25 in total

1.  Brain metastases in malignant pleural mesothelioma.

Authors:  Tomoko Yamagishi; Nobukazu Fujimoto; Yosuke Miyamoto; Michiko Asano; Yasuko Fuchimoto; Sae Wada; Kenichi Kitamura; Shinji Ozaki; Hideyuki Nishi; Takumi Kishimoto
Journal:  Clin Exp Metastasis       Date:  2015-11-30       Impact factor: 5.150

2.  Malignant peritoneal mesothelioma presenting umbilical hernia and Sister Mary Joseph's nodule.

Authors:  Kota Tsuruya; Masashi Matsushima; Takayuki Nakajima; Mia Fujisawa; Katsuya Shirakura; Muneki Igarashi; Jun Koike; Takayoshi Suzuki; Tetsuya Mine
Journal:  World J Gastrointest Endosc       Date:  2013-08-16

3.  Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.

Authors:  Yoshiki Negi; Kozo Kuribayashi; Norihiko Funaguchi; Hiroshi Doi; Koji Mikami; Toshiyuki Minami; Teruhisa Takuwa; Takashi Yokoi; Seiki Hasegawa; Takashi Kijima
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

4.  Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.

Authors:  Gouji Toyokawa; Mitsuhiro Takenoyama; Fumihiko Hirai; Ryo Toyozawa; Eiko Inamasu; Miyako Kojo; Yosuke Morodomi; Yoshimasa Shiraishi; Tomoyoshi Takenaka; Masafumi Yamaguchi; Mototsugu Shimokawa; Takashi Seto; Yukito Ichinose
Journal:  Int J Clin Oncol       Date:  2013-10-26       Impact factor: 3.402

Review 5.  Recent Scientific Evidence Regarding Asbestos Use and Health Consequences of Asbestos Exposure.

Authors:  Manuela Valenzuela; Margarita Giraldo; Sonia Gallo-Murcia; Juliana Pineda; Laura Santos; Juan Pablo Ramos-Bonilla
Journal:  Curr Environ Health Rep       Date:  2016-12

6.  Effects of hyaluronic acid and CD44 interaction on the proliferation and invasiveness of malignant pleural mesothelioma.

Authors:  Takeshi Hanagiri; Shinji Shinohara; Masaru Takenaka; Yoshiki Shigematsu; Manabu Yasuda; Hidehiko Shimokawa; Yoshika Nagata; Makoto Nakagawa; Hidetaka Uramoto; Tomoko So; Fumihiro Tanaka
Journal:  Tumour Biol       Date:  2012-08-11

7.  Retrospective analysis of large-scale research screening of construction workers for the early diagnosis of mesothelioma.

Authors:  Tomoko Hirohashi; Kiyoko Igarashi; Masaaki Abe; Masahiro Maeda; Okio Hino
Journal:  Mol Clin Oncol       Date:  2013-10-02

8.  CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma.

Authors:  Masayuki Watanabe; Tomohito Higashi; Kana Ozeki; Atsuko Y Higashi; Kotaro Sugimoto; Hayato Mine; Hironori Takagi; Yuki Ozaki; Satoshi Muto; Naoyuki Okabe; Yuki Matsumura; Takeo Hasegawa; Yutaka Shio; Hiroyuki Suzuki; Hideki Chiba
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

9.  Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region.

Authors:  Hidetaka Uramoto; Tomoya Takiguchi; Tomonobu Koizumi; Azusa Tanimoto; Ryuji Hayashi; Yozo Nakazawa; Ken-Ichi Ito; Mitsutoshi Nakada; Yasuo Hirono; Yoshikazu Nishino; Seiji Yano
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-29       Impact factor: 4.322

10.  Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: A case report and review of the literature.

Authors:  Noriko Inagaki; Kayoko Kibata; Takeshi Tamaki; Toshiki Shimizu; Shosaku Nomura
Journal:  Oncol Lett       Date:  2013-07-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.